Ferric carboxymaltose
Ferric carboxymaltose is a pharmaceutical drug with 75 clinical trials. Currently 5 active trials ongoing. Historical success rate of 83.7%.
Success Metrics
Based on 41 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
56
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.9%
41 of 54 finished
24.1%
13 ended early
5
trials recruiting
75
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency
An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
Patient Blood Management In CARdiac sUrgical patientS
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
Clinical Trials (75)
Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency
An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
Patient Blood Management In CARdiac sUrgical patientS
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)
Neuroimaging Ancillary Study
Perioperative Management in Gynaecological Carcinoma Surgery
The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures
Hypoferritinemia Without Anemia Among Reproductive Age Females
Postoperative Replacement of Intraoperative Iron Losses
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients
Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial
Preoperative i.v. Iron Substitution in Patients With Colon Cancer
Iron in Patients With Cardiovascular Disease
RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 75